Bloomberg Fortis Healthcare Ltd.’s board passed over bids backed by US private-equity giants TPG and KKR & Co. in favour of local tycoons in the contentious battle for control of India’s second-largest hospital chain. The drawn-out takeover fight moved a step closer to a conclusion after the Fortis board chose a joint proposal from two Indian business families. The rejected ...

Bloomberg Shanghai Fosun Pharmaceutical Group Co. is among shortlisted bidders for a portfolio of Novartis AG assets, including its US dermatology business, that could fetch as much as $2 billion, people with knowledge of the matter said. Apollo Global Management LLC, CVC Capital Partners and Indian drugmaker Aurobindo Pharma Ltd. have also been picked to make final offers, the people ...

Bloomberg It’s hard to predict whether India will re-elect a majority government next year. But one fund manager has advice for investors: go against the crowd. If stocks start to rise on expectations of a stable administration, investors must book profit and re-enter should the results confirm the outcome, said Nilesh Shah, who oversees $19 billion as chief executive officer ...